How effective is Nanodropper in reducing topical medication waste?
Products

How effective is Nanodropper in reducing topical medication waste?

Research tests the use of the Nanodropper Bottle Adaptor for volume reduction compared to standard eye drops.
Anatomical brain changes noted in patients with restored vision
Research

Anatomical brain changes noted in patients with restored vision

“Window of plasticity” for some visual tasks extends further than previous research has suggested.
Inaugural dry eye forum kicks off summer series
Events

Inaugural dry eye forum kicks off summer series

Eyes On Eyecare successfully launches the first series with the four-part dry eye implementation program.
Enrollment opens for Clearside Biomedical's ODYSSEY phase 2b trial for wet AMD
Pipeline

Enrollment opens for Clearside Biomedical's ODYSSEY phase 2b trial for wet AMD

CLS-AX is being assessed for suprachoroidal delivery using the company’s proprietary CSC Microinjector.
Target enrollment achieved in trial for RP associated with Usher syndrome
Pipeline

Target enrollment achieved in trial for RP associated with Usher syndrome

The phase 1/2 study is assessing NPI-001, developed to block oxidative stress associated with RP and other blinding eye diseases.
Positive 12-month data reported in Coave's ongoing RP phase 1/2 trial
Pipeline

Positive 12-month data reported in Coave's ongoing RP phase 1/2 trial

Gene therapy candidate targets treatment for a rare form of retinitis pigmentosa: PDE6B RP.
Optos releases new UWF color image modality for retinal disease
Products

Optos releases new UWF color image modality for retinal disease

Latest feature expands capabilities of the company’s California FA retinal imaging medical device.
Physical activity may relieve DED symptoms
Research

Physical activity may relieve DED symptoms

Meta-analysis shows the positive impact of long-term physical activity on DED symptoms.
Proposed bill bans contact lens prescription robocalls
Legal

Proposed bill bans contact lens prescription robocalls

Bipartisan legislation seeks to address patient safety concerns and crack down on online retailer federal requirements.
Norlase secures $11 million following ECHO approval
Business

Norlase secures $11 million following ECHO approval

Announcement follows the recent FDA clearance and CE mark earlier this month.
Two-year data on OMNI Surgical System shows promise for POAG patients
Research

Two-year data on OMNI Surgical System shows promise for POAG patients

Results support previous findings for the longest multicenter study on the surgical system for standalone and combination-cataract surgery.
Physical chemistry mechanism may fight against AMD
Research

Physical chemistry mechanism may fight against AMD

Melanin contributes to reduced levels of lipofuscin, study finds.
Is secondhand smoking tied to pediatric myopia?
Research

Is secondhand smoking tied to pediatric myopia?

Study shows young children exposed to secondhand smoke have a higher risk of moderate and high myopia.
4DMT reports positive interim data from phase 1/2 wet AMD trial
Pipeline

4DMT reports positive interim data from phase 1/2 wet AMD trial

4D Molecular Therapeutics’ intravitreal study on novel genetic medicine indicates well-tolerance for all doses.
Ray Therapeutics secures $100 million in funding for optogenetic gene therapy programs
Business

Ray Therapeutics secures $100 million in funding for optogenetic gene therapy programs

Company plans on using funding to target inherited retinal diseases.
Annexon releases topline data for phase 2 GA study
Pipeline

Annexon releases topline data for phase 2 GA study

ARCHER trial is assessing ANX007 as the first complement therapy for preserving visual acuity. 
Do lifestyle habits influence glaucoma risk?
Research

Do lifestyle habits influence glaucoma risk?

Eating breakfast, avoiding late dinner, and other routines may be linked to reduced risk of glaucoma development.
Graybug Vision and Mireca terminate IRD partnership
Business

Graybug Vision and Mireca terminate IRD partnership

All intellectual property rights will revert back to Mireca.
Alimera completes patient enrollment for DME study on ILUVIEN
Pipeline

Alimera completes patient enrollment for DME study on ILUVIEN

NEW DAY study is evaluating the intravitreal implant as a baseline therapy compared to aflibercept.
GMAC launches myopia awareness summer campaign
Events

GMAC launches myopia awareness summer campaign

First phase focuses on educational resources and social outreach for eye care and health care professionals.